| Year |
Citation |
Score |
| 2005 |
Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J. Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 114-20. PMID 15632041 |
0.433 |
|
| 2004 |
Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J. Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 47-54. PMID 15018828 DOI: 10.1016/S1536-1632(03)00107-0 |
0.497 |
|
| 2003 |
Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J. Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 232-9. PMID 14499138 DOI: 10.1016/S1536-1632(03)00086-6 |
0.499 |
|
| 2002 |
Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clinical Nephrology. 57: 56-62. PMID 11837802 |
0.441 |
|
| Show low-probability matches. |